Primobolan-200 Methenolone Enanthate Oil Steroids Injectable 200mg/ml

Description

Primobolan Methenolone Enanthate Injectable Research

Specification Sheet

• CAS Number: 303-42-4
• Molecular Formula: C27H42O3
• Molecular Weight: 414.62 g/mol
• Appearance: Clear to pale yellow viscous solution
• Purity: >99% confirmed via HPLC-UV and GC/MS
• Appearance: Clear, pale yellow viscous solution
• Solubility: Optimized in organic carrier lipids including Grapeseed Oil and Ethyl Oleate

Pharmacodynamics

The pharmacology of Primobolan Methenolone Enanthate is defined by its structural resistance to the aromatase enzyme and its unique 1-methyl substitution. Methenolone molecules bind to the nuclear androgen receptor (AR) to trigger the translocation of the receptor complex into the cell nucleus. The 1-methyl modification protects the molecule from 3α-hydroxysteroid dehydrogenase deactivation in skeletal muscle tissue. Androgen signaling enhances myogenic protein transcription by up-regulating the efficiency of amino acid transport across the sarcolemma. Furthermore, the Enanthate ester regulates the liberation rate from the intramuscular lipid depot, providing a terminal half-life of approximately 10.5 days (±1.2 days). Binding kinetics indicate a lower binding affinity than native testosterone, but the absence of estrogenic or progestogenic activity allows for precise studies on pure anabolic pathways. Unlike Testosterone, methenolone exhibits zero conversion to estrogen, effectively eliminating fluid retention as a confounding variable in metabolic research.

About This Compound

Methenolone Enanthate, recognized in research communities as Primobolan, is a synthetic 1-methyl-derivative of dihydrotestosterone (DHT) engineered for sustained anabolic signaling with minimal androgenic secondary effects. Methenolone molecules bind to the nuclear androgen receptor (AR) with high selectivity to initiate myogenic gene transcription. Researchers prioritize this oil-based parenteral delivery system for investigating long-term tissue preservation and the modulation of nitrogen balance in controlled biological environments.

Research Observations

• Lean Tissue Accrual: Experimental data suggests steady increases in high-quality muscle mass characterized by a complete absence of subcutaneous water retention.
• Lipolytic Modulation: Based on community feedback, effects include improved nutrient partitioning and accelerated fat loss in calorie-restricted research models.
• Nitrogen Retention: Published research indicates a profound shift in nitrogen retention, protecting muscle tissue during metabolic stressors.
• Immune Pathway Interaction: Observed effects in research models include the stabilization of red blood cell counts and potential support for lymphoid tissue.
• Strength Performance: The typical user-reported experience involves a gradual trajectory in maximal force production without significant neurological strain.

Key Points:
Methenolone Enanthate remains a foundational research tool for inducing non-aromatizing anabolic shifts and studying tissue remodeling with a favorable safety-to-potency ratio.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.